Cardiovascular safety, cancer and Jak-inhibitors: Differences to be highlighted

• Main Authors: Maurizio Benucci (Author), Arianna Damiani (Author), Maria Infantino (Author), Mariangela Manfredi (Author), Barbara Lari (Author), Valentina Grossi (Author), Francesca Li Gobbi (Author), Piercarlo Sarzi-Puttini (Author)
• Format: Book
• Published: Elsevier, 2022-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Rheumatoid arthritis (RA) is a chronic inflammatory disease whose natural history leads to articular and extra-articular damage. Both cardiovascular risk and malignancy risk results higher in RA patients, compared to general population. Janus kinase inhibitors (JAKis) are oral targeted synthetic dis...